Literature DB >> 18444854

Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key.

Dirk Werber1, Brendan W Mason, Meirion R Evans, Roland L Salmon.   

Abstract

BACKGROUND: Preventing household transmission of Shiga toxin-producing Escherichia coli O157 (STEC O157) infection is important because of the ease of interpersonal transmission and the potential disease severity.
METHODS: We conducted a retrospective cohort study of households associated with an outbreak of STEC O157 infection in South Wales, United Kingdom, in autumn 2005. We investigated whether characteristics of the primary case patient or the household were predictors for secondary household transmission of STEC O157 infection. Furthermore, we estimated the proportion of cases that might be prevented by isolation (e.g., hospitalization) of the primary case patient immediately after the microbiological diagnosis and the number of patients with STEC O157 who would need to be isolated to prevent 1 case of hemolytic uremic syndrome. Based on dates of symptom onset, case patients in households were classified as having primary, coprimary, or secondary infection. Secondary cases were considered to be preventable if the secondary case patient's symptoms started >1 incubation period (4 days) after the date of microbiological diagnosis of the primary case.
RESULTS: Eighty-nine (91%) of 98 eligible households were enrolled. Among 20 households (22%), 25 secondary cases were ascertained. Thirteen secondary cases (56%) occurred in siblings of the primary case patients; hemolytic uremic syndrome developed in 4 of these siblings. Presence of a sibling (risk ratio, 3.8; 95% confidence interval, 0.99-14.6) and young age (<5 years) of the primary case patient (risk ratio, 2.03; 95% confidence interval, 0.99-41.6) were independent predictors for households in which secondary cases occurred. Of the 15 secondary cases for which complete information was available, 7 (46%) might have been prevented. When restricting isolation to primary case patients who were aged <10 years and who had a sibling, we estimated the number of patients who would need to be isolated to prevent 1 case of hemolytic uremic syndrome to be 47 patients (95% confidence interval, 16-78 patients).
CONCLUSIONS: Promptly separating pediatric patients with STEC O157 infection from their young siblings should be considered.

Entities:  

Mesh:

Year:  2008        PMID: 18444854     DOI: 10.1086/587670

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Therapy: Azithromycin and decolonization after HUS.

Authors:  Michael E Seifert; Phillip I Tarr
Journal:  Nat Rev Nephrol       Date:  2012-05-01       Impact factor: 28.314

2.  Shiga toxin-producing Escherichia coli in Peruvian children with bloody diarrhea.

Authors:  Alejandro Llanos; Jorge Lee; Francisco López; Carmen Contreras; Francesca Barletta; Elsa Chea-Woo; Claudia Ugarte; Thomas G Cleary; Theresa J Ochoa
Journal:  Pediatr Infect Dis J       Date:  2012-03       Impact factor: 2.129

3.  Bloody diarrhoea: Test early for verotoxin producing Escherichia coli.

Authors:  Roland L Salmon; Meirion R Evans; Brendan W Mason; Dirk Werber
Journal:  BMJ       Date:  2008-05-24

4.  Point: Should all stools be screened for Shiga toxin-producing Escherichia coli?

Authors:  Mario J Marcon
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

5.  Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.

Authors:  Craig S Wong; Jody C Mooney; John R Brandt; Amy O Staples; Srdjan Jelacic; Daniel R Boster; Sandra L Watkins; Phillip I Tarr
Journal:  Clin Infect Dis       Date:  2012-03-19       Impact factor: 9.079

6.  Real-Time PCR Assay for Detection and Differentiation of Shiga Toxin-Producing Escherichia coli from Clinical Samples.

Authors:  Xuan Qin; Eileen J Klein; Emmanouil Galanakis; Anita A Thomas; Jennifer R Stapp; Shannon Rich; Anne Marie Buccat; Phillip I Tarr
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

Review 7.  Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology.

Authors:  Maite Muniesa; Jens A Hammerl; Stefan Hertwig; Bernd Appel; Harald Brüssow
Journal:  Appl Environ Microbiol       Date:  2012-04-13       Impact factor: 4.792

Review 8.  Escherichia coli O157:H7: animal reservoir and sources of human infection.

Authors:  Witold A Ferens; Carolyn J Hovde
Journal:  Foodborne Pathog Dis       Date:  2010-11-30       Impact factor: 3.171

Review 9.  Escherichia coli O157: what every internist and gastroenterologist should know.

Authors:  Mary F Bavaro
Journal:  Curr Gastroenterol Rep       Date:  2009-08

10.  Contamination Scenario Matters when Using Viral and Bacterial Human-Associated Genetic Markers as Indicators of a Health Risk in Untreated Sewage-Impacted Recreational Waters.

Authors:  Mary E Schoen; Alexandria B Boehm; Jeffrey Soller; Orin C Shanks
Journal:  Environ Sci Technol       Date:  2020-10-08       Impact factor: 9.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.